| Status | Study |
| Recruiting |
Study Name: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Date: 2015-09-30 Interventions: Drug: Fludarabine Given IV |
| Recruiting |
Study Name: Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA Condition: Myelodysplastic Syndrome MDS Refract Date: 2015-09-25 Interventions: Drug: rigosertib Patients will |
| Recruiting |
Study Name: Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Date: 2015-07-27 Interventions: Drug: Azacitidine Given intrav |
| Recruiting |
Study Name: Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias Condition: Angiodysplasia Vascular Malformations Gastrointestinal Hem Date: 2015-03-04 Interventions: Drug: Octreotide Two injections of 20 mg will be given monthly. |
| Active, not recruiting |
Study Name: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Condition: Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Date: 2013-08-21 Interventions: Drug: rigosertib sodium Other Names: ON 01910.Na SyB L-1101 |
| Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-06-04 Interventions: Other: antitumor drug screening assay |
| Active, not recruiting |
Study Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Date: 2013-04-12 Interventions: Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401 |
| Completed |
Study Name: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk Date: 2013-04-08 Interventions: Drug: pravastatin sodium Given |
| Completed |
Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2013-02-07 Interventions: Drug: vorinostat Given PO |
| Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2013-01-02 Interventions: Drug: Fludarabine phosphate Gi |